Advertisement

Cibus, Inc. CBUS

Set alert

Price alert · CBUS

All alert types
1.29 USD -0.06 -4.44%

At close · Oct 30

1.30 +0.01 +0.78%

After hours · Oct 30, 4:00 PM ET

Bid
1.30 × 1
Ask
1.31 × 2
1.27 Day range 1.40
1.16 52-week range 4.05
YTD
-25.86%
1 year
-16.23%
Open
1.36
Prev close
1.35
Mkt cap
98.59M
Vol
52.98K
Avg vol
116.97K
EPS
-1.62
P/E
0.00
Div yield
0.00%
More statistics
Low
1.27
High
1.40
Forward P/E
-1.09
Beta
1.79
Short ratio
14.59
Inst. own
33.74%
Dividend
0.00
Ex-div date
50-d avg
4.14
200-d avg
9.75
1y target
18.13

2Y chart

Chart tools
Interval

Events in this range
  • Nov 7, 2024Earnings: 0.06; estimate -0.9; surprise 106.67%
  • Nov 11, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (82)
NameDateAgo
MACD: Sell SignalOct 30, 20262 days ago
MACD: Buy SignalOct 28, 20264 days ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BearishOct 5, 20263 weeks ago
SMA: BullishOct 2, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 28, 20261 month ago
MACD: Buy SignalSep 17, 20261 month ago
SMA: BearishAug 25, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BearishAug 18, 20262 months ago
SMA: BearishAug 14, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BullishJul 28, 20263 months ago
SMA: BearishJul 22, 20263 months ago
MACD: Sell SignalJul 22, 20263 months ago
SMA: BullishJul 21, 20263 months ago
SMA: BearishJul 16, 20263 months ago
SMA: BullishJul 8, 20263 months ago
RSI: OverboughtJul 8, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 16, 20264 months ago
MACD: Sell SignalJun 9, 20264 months ago
MACD: Buy SignalApr 20, 20266 months ago
RSI: OversoldApr 9, 20266 months ago
SMA: BearishApr 7, 20266 months ago
SMA: BearishMar 26, 20267 months ago
SMA: BullishMar 23, 20267 months ago
SMA: BearishMar 20, 20267 months ago
MACD: Sell SignalMar 16, 20267 months ago
RSI: OverboughtMar 11, 20267 months ago
MACD: Buy SignalMar 10, 20267 months ago
MACD: Sell SignalMar 5, 20268 months ago
RSI: OverboughtFeb 23, 20268 months ago
RSI: OverboughtFeb 17, 20268 months ago
MACD: Buy SignalFeb 13, 20268 months ago
MACD: Sell SignalFeb 12, 20268 months ago
MACD: Buy SignalFeb 2, 20269 months ago
SMA: BullishJan 26, 20269 months ago
SMA: BullishJan 23, 20269 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BearishJan 21, 20269 months ago
MACD: Sell SignalJan 14, 20269 months ago
RSI: OverboughtJan 6, 20269 months ago
SMA: BullishDec 30, 202510 months ago
SMA: BearishDec 29, 202510 months ago
SMA: BullishDec 24, 202510 months ago
SMA: BearishDec 23, 202510 months ago
SMA: BullishDec 19, 202510 months ago
SMA: BearishDec 12, 202510 months ago
SMA: BullishDec 11, 202510 months ago
SMA: BullishDec 3, 202511 months ago
SMA: BearishDec 2, 202511 months ago
SMA: BullishDec 1, 202511 months ago
MACD: Buy SignalNov 25, 202511 months ago
SMA: BearishNov 4, 202512 months ago
MACD: Sell SignalOct 30, 20251 year ago
SMA: BullishOct 2, 20251 year ago
MACD: Buy SignalOct 1, 20251 year ago
MACD: Sell SignalSep 29, 20251 year ago
MACD: Buy SignalAug 28, 20251 year ago
MACD: Sell SignalAug 8, 20251 year ago
MACD: Buy SignalAug 4, 20251 year ago
MACD: Sell SignalAug 1, 20251 year ago
MACD: Buy SignalJul 2, 20251 year ago
SMA: BearishJun 5, 20251 year ago
MACD: Sell SignalJun 4, 20251 year ago
SMA: BullishApr 30, 20251 year ago
SMA: BearishApr 29, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 17, 20251 year ago
MACD: Sell SignalMar 27, 20251 year ago
SMA: BearishMar 20, 20251 year ago
SMA: BullishMar 19, 20251 year ago
MACD: Buy SignalMar 5, 20251 year ago
RSI: OversoldFeb 27, 20251 year ago
RSI: OversoldFeb 24, 20251 year ago
MACD: Sell SignalFeb 21, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago

Key statistics

Market cap
83.97M
Enterprise value
90.65M
Trailing P/E
0.00
Forward P/E
-1.09
PEG ratio
0.00
Price / sales
20.22
Price / book
0.69
EPS (TTM)
-45.95
Beta
1.79
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
4.15M
Revenue growth
250.90%
Free cash flow
-48.61M
Total cash
28.80M
Total debt
36.74M
Return on equity
-149.74%
Shares outstanding
26.46M
Short % of float
12.40%
50-day average
4.14
200-day average
9.75

Analyst view

Consensus: buy

Buy
Price target (mean) 18.13 +1305.0% upside
Target (low)
4.00
Target (mean)
18.13
Target (high)
25.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.85.

Earnings history

Financials — quick view

All financials
CBUS Revenue — quarterly 994.00K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CBUS Net income — quarterly -22.14M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CBUS EPS — quarterly -0.29
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CBUS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.900.06+0.96+106.67%
Aug 8, 2024Jun 1, 2024-0.81-1.14-0.33-40.74%
May 9, 2024Mar 1, 2024-1.01-1.12-0.11-10.89%
Mar 21, 2024Dec 1, 2023-1.12-1.16-0.04-3.57%
Nov 9, 2023Sep 1, 2023-1.18-1.59-0.41-34.75%
Aug 9, 2023Jun 1, 2023-0.30-3.05-2.75-916.67%

Upgrades / downgrades

CBUS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024HC Wainwright & Co.reitBuyBuy
Oct 22, 2024Canaccord GenuitymainBuyBuy
Sep 24, 2024Alliance Global PartnersmainBuyBuy
Sep 19, 2024Canaccord GenuitymainBuyBuy
Aug 12, 2024Canaccord GenuitymainBuyBuy
Jul 29, 2024Alliance Global Partnersinit—Buy

About Cibus, Inc.

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
cibus.com

News

Your note

Sign in to keep a note on CBUS — it syncs with the Stock Master app.

Insider holders

CBUS insider holders
InsiderRelationLatest transactionDateShares held
BROOS CORNELISChief Financial OfficerSaleNov 11, 202474,197
CARR MICHAEL AChief Executive OfficerStock Award(Grant)May 30, 202333,174
FREY TRAVISChief Technology OfficerStock Award(Grant)May 30, 202319,060
FRIMERMAN DEBRA H.General CounselStock Award(Grant)May 30, 202318,772
GOCAL GREG FRANCIS WILLIAMOfficerSaleJul 14, 2024314,844
KING WADE HAMPTON M.D.Chief Financial OfficerStock Award(Grant)May 30, 2023212,100

Institution ownership

CBUS institution ownership
Holder% heldSharesValueReported
FMR, LLC14.79%3,913,27911.11MSep 29, 2024
Vantage Consulting Group, Inc4.32%1,143,9493.25MSep 29, 2024
Blackrock Inc.4.04%1,068,3423.03MSep 29, 2024
Vanguard Group Inc3.17%838,9522.38MSep 29, 2024
Geode Capital Management, LLC1.38%364,9231.04MSep 29, 2024
State Street Corporation1.16%307,262872.62KSep 29, 2024

Fund ownership

CBUS fund ownership
Holder% heldSharesValueReported
Fidelity Growth Company Fund4.61%1,218,6743.46MOct 30, 2024
Vanguard Total Stock Market Index Fund1.76%465,3861.32MSep 29, 2024
iShares Russell 2000 ETF1.45%382,2841.09MOct 30, 2024
Fidelity Growth Company K6 Fund1.41%373,1531.06MOct 30, 2024
Fidelity Series Growth Company Fund1.26%332,232943.54KOct 30, 2024
Vanguard Extended Market Index Fund1.00%264,388750.86KSep 29, 2024
Advertisement